Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-09-23

Clinical Trial Update: Effect of an Anterior Chamber Infusion System on Trabeculectomy Outcomes [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating an anterior chamber infusion system to improve trabeculectomy outcomes for glaucoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Queen's University | Conditions: Glaucoma | Phase 1 | Status: WITHDRAWN